Kim; Dae-Kee

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kim; Dae-Kee.The latest application filed is for "process for producing and purifying factor viii and its derivatives".

Company Profile

2.14.15

Kim; Dae-Kee - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of treating fibrosis, cancer and vascular injuries Grant RE47,141 - Kim , et al. Nov	2018-11-27
2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors Grant RE47,122 - Kim , et al. November 13, 2	2018-11-13
Process for producing and purifying factor VIII and its derivatives Grant 9,926,361 - Song , et al. March 27, 2	2018-03-27
Process For Producing And Purifying Factor Viii And Its Derivatives App 20160347819 - Song; In-Young ; et al.	2016-12-01
Process for producing and purifying factor VIII and its derivatives Grant 9,441,030 - Song , et al. September 13, 2	2016-09-13
2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors App 20130245066 - Kim; Dae-Kee ; et al.	2013-09-19
Methods of treating fibrosis, cancer and vascular injuries Grant 8,513,222 - Kim , et al. August 20, 2	2013-08-20
2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors Grant 8,420,685 - Kim , et al. April 16, 2	2013-04-16
Methods of Treating Fibrosis, Cancer and Vascular Injuries App 20110319408 - Kim; Dae-Kee ; et al.	2011-12-29
2-pyridyl Substituted Imidazoles As Therapeutic Alk5 And/or Alk4 Inhibitors App 20110319406 - Kim; Dae-Kee ; et al.	2011-12-29
2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors Grant 8,080,568 - Kim , et al. December 20, 2	2011-12-20
Process For Producing And Purifying Factor Viii And Its Derivatives App 20100112641 - Song; In-Young ; et al.	2010-05-06
.alpha.,.beta.-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors Grant 7,495,022 - Kim , et al. February 24, 2	2009-02-24
2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors App 20080319012 - Kim; Dae-Kee ; et al.	2008-12-25
2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors App 20080319022 - Kim; Dae-Kee ; et al.	2008-12-25
2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors Grant 7,407,958 - Kim , et al. August 5, 2	2008-08-05
Factor VIII polypeptide Grant 7,041,635 - Kim , et al. May 9, 2	2006-05-09
2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors App 20050261299 - Kim, Dae-Kee ; et al.	2005-11-24
Pyrrolopyrimidinone derivatives, process of preparation and use Grant 6,962,911 - Kim , et al. November 8, 2	2005-11-08
Pyrrolopyrimidinone derivatives, process for preparation thereof, and method of using and composition comprising them App 20050130983 - Kim, Dae-Kee ; et al.	2005-06-16
Alpha, beta-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors App 20050124679 - Kim, Dae-Kee ; et al.	2005-06-09
Method of diagnosing systemic lupus erythematosus App 20040180385 - Jeoung, Dooil ; et al.	2004-09-16
Factor VIII polypeptide App 20040147436 - Kim, Hun-Taek ; et al.	2004-07-29
Pyrrolopyrimidinone derivatives, process of preparation and use App 20030171361 - Kim, Dae-Kee ; et al.	2003-09-11
Cage antigen App 20030092083 - Jeoung, Doo-il ; et al.	2003-05-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.